Board of directors

Per Wold-Olsen
Per Wold-Olsen Bill Hoover Wolfgang Reim Carsten Krogsgaard Thomsen Hélène Barnekow Ronica Wang Leo Larsen Morten Andersen Nikolai Bisgaard
Per Wold-Olsen
Born: 1947
Nationality: Norwegian

Joined the board and appointed chairman in 2008

Chairman of the remuneration committee
Chairman of the nomination committee 
Member of the strategy committee

No. of shares in GN: 224,884

Fiduciary positions: Chairman of the board in Medicine for Malaria Venture

Member of the boards in Exiqon A/S, Gilead Sciences Inc. and Novo A/S

Position: Formerly, President Merck & Co., Inc., US Intercontinental Division

Per brings a unique set of capabilities and values to the board of GN Store Nord within marketing, product development as well as commercialization of innovation

Per has an extensive global leadership expertise and knowledge of the healthcare industry from his many years at the leadership team of Merck & Co., Inc. - a US based Fortune 500 company. Per also possesses in depth knowledge of the US market as well as emerging markets.

Per holds an MBA, and he started his career as Managing Director in the pharmaceutical company MSD Norway from 1976-1991. From 1991, Per worked in Merck & Co., Inc. in various assignments of increasing responsibility. From 1994 to 2006 Per was a member of Merck’s Management Committee.

Complies with the Committee on Corporate Governance’s definition of independency